On November 5, 2025, Context Therapeutics Inc. reported its third quarter financial results and provided updates on ongoing clinical trials, enrolling 12 patients in its CTIM-76 trial with promising anti-tumor activity.
AI Assistant
CONTEXT THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.